Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Don’t Miss

29 Nov 2021

News You Might Have Missed: November 29, 2021

Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed....

By Microdose

Events

25 Nov 2021

Post-Wonderland Debrief: Alvarius Pharmaceuticals

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Events

24 Nov 2021

Post-Wonderland Debrief: Mindset Pharma

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Events

24 Nov 2021

Post-Wonderland Debrief: Numinus Wellness

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Events

23 Nov 2021

Post-Wonderland Debrief: Wesana Health

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Events

22 Nov 2021

Post-Wonderland Debrief: H.C. Wainwright & Co.

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors....

By Microdose

Don’t Miss

22 Nov 2021

News You Might Have Missed: November 22, 2021

Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed....

By Microdose

Science

18 Nov 2021

Exclusive Scientific Report: Leveraging Cellular Communication for Psychedelic Drug Development and Treatment

What cellular communication in the brain underlies such disruption in daily activities? Does the gut play a role? What is the cellular language of orchestrated biological activity? What happens when...

By Microdose

Events

17 Nov 2021

The 1st Annual Microdose Awards

The 1st Annual Microdose Awards Sponsored by Congratulations to all the winners and thank you to everyone who voted in the 1st Annual Microdose Awards....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.